In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...

A new partnership between Walmart and drug maker Eli Lily will make it easier for people to access the super-popular weight loss drug Zepbound.

The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...

A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world’s hardest to quit ...

A new test developed at Washington State University will help pharmaceutical companies, veterinarians and regulatory agencies ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for ...

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...

Mistry described Scp776 as a “designer drug.” She explained that IGF-1 receptors are abundant throughout the body, and IGF-1 ...

To break it down, while hair loss itself is not directly a side effect of the drug, losing weight rapidly, can cause telogen ...

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...